Naltrexone
Active ingredient: Naltrexone
Delivery: from 4 days
- Worldwide Delivery4-7 business days
- Quality GuaranteedOnly original products
- Bonus pillsSave up to 80%
- 24/7 SupportOur team of pharmacists is available 24/7 to help you
Naltrexone blocks opioid receptors and reduces the rewarding effects linked with opioids and alcohol. Naltrexone pills are used for adults with opioid dependence or alcohol use disorder after appropriate withdrawal management. Treatment works best alongside recovery planning and psychosocial support.
Product information
Naltrexone is a medicine containing naltrexone hydrochloride, an opioid antagonist. It belongs to a category of medicines that block opioid receptors and is used in alcohol use disorder and opioid dependence.
How it affects the body
Naltrexone is an opioid antagonist that attaches to opioid receptors without activating them. This blocks the euphoric effects of opiate drugs and reduces the rewarding effects linked with opioids and alcohol. Naltrexone can also block opioid pain relief.
Ingredients
Naltrexone contains naltrexone hydrochloride, an opioid antagonist. An opioid antagonist attaches to opioid receptors without activating them, so opioid drugs have less ability to produce euphoria. An opioid receptor is a cell target involved in pain control, reward, breathing, and dependence.
Naltrexone supports relapse prevention. It does not treat acute alcohol withdrawal, replace opioid detoxification, or remove the need for counselling and ongoing recovery support. The FDA prescribing information describes naltrexone as a treatment used within a broader plan for alcohol dependence and opioid dependence [1].
Naltrexone hydrochloride active ingredient
Naltrexone hydrochloride is converted into active naltrexone in the body. Its pharmacological action is different from methadone and buprenorphine, which activate opioid receptors to varying degrees. Naltrexone does not produce opioid-like intoxication when taken as prescribed.
The response is individual. Some people experience fewer urges or less reward from drinking, while others need a different treatment strategy, closer support, or another form of relapse prevention.
Opioid receptor blockade
Naltrexone blocks the euphoric effects of opiate drugs, including medicines and illicit opioids that act at opioid receptors. It can also block opioid pain relief, which matters during dental procedures, surgery, emergency treatment, and injury care.
Dosage and administration
The dose is decided individually, taking age, other medicines, and health conditions into account. Prescribers consider opioid-free status, treatment history, liver health, kidney function, adherence, and the reason for treatment before selecting the schedule.
Naltrexone pills are taken by mouth according to the prescribed regimen. The appropriate amount and schedule vary between individuals and must not be self-adjusted.
- Take the pill at the prescribed time and follow the schedule provided by the treating clinician.
- Do not take extra tablets to compensate for a missed dose.
- If a dose is missed, take the next dose only as directed by the prescriber or treatment service.
- Do not start treatment after recent opioid exposure without clinical assessment.
- Tell the prescriber about prescription painkillers, cough medicines, diarrhoea treatments, methadone, buprenorphine, and non-prescription opioid products.
- Keep the medication list current if the treatment schedule changes.
Oral and long-acting forms differ. These approaches should not be treated as interchangeable because their timing, monitoring, and missed-dose procedures differ.
When not to use it
Naltrexone is not suitable for a person who is currently using opioids, has physiological opioid dependence, is in acute opioid withdrawal, has a positive opioid test, or has not completed the opioid-free preparation required for treatment.
Relevant exposure includes:
- morphine and other prescription opioid pain medicines;
- methadone;
- buprenorphine, including Buvidal;
- heroin and other opiate drugs;
- opioid-containing cough or diarrhoea medicines;
- medicines obtained during emergency or dental treatment.
Current opioid use, pregnancy-related treatment needs, uncontrolled withdrawal, severe liver disease, or an inability to complete opioid-free preparation may change the treatment choice.
When this is not for you
Naltrexone is NOT for you if you are currently using opioids, have not completed opioid-free preparation, or cannot follow the monitoring plan. Do not begin it after taking an opioid painkiller, cough medicine, diarrhoea treatment, methadone, buprenorphine, heroin, or another opiate without speaking to a clinician. Returning to a previous opioid dose after stopping treatment can produce overdose.
Possible side effects
Nausea, abdominal discomfort, headache, dizziness, fatigue, reduced appetite, and sleep changes can occur with naltrexone. Some people notice vivid dreams or difficulty sleeping, while others feel tired during the day. Symptoms may be more noticeable when treatment begins.
Taking the medicine exactly as prescribed can make tolerability easier to assess. Do not change the dose to manage nausea, fatigue, or sleep disturbance without specific instructions.
Common problems often improve as the body adjusts. Persistent vomiting, worsening abdominal pain, or inability to maintain fluids needs medical assessment because dehydration and liver problems can present with similar symptoms.
Common adverse effects
Possible effects include:
- nausea or stomach discomfort;
- headache or dizziness;
- tiredness or reduced energy;
- changes in sleep or dreams;
- anxiety, irritability, or low mood;
- reduced appetite;
- joint or muscle discomfort.
A mild symptom may be monitored, but a severe or persistent symptom requires prompt clinical review. Naltrexone can affect people differently, especially when alcohol use, liver disease, or several medicines are involved.
Liver injury warning signs
Urgent assessment is needed for yellowing of the skin or eyes, dark urine, unusually pale stools, severe pain under the right ribs, persistent vomiting, marked loss of appetite, or unusual weakness. Liver monitoring may be appropriate when there is pre-existing liver disease, heavy alcohol use, or treatment with other medicines that affect the liver.
Emergency help is required for facial swelling, breathing difficulty, widespread blistering rash, fainting, or severe confusion. Unexpected withdrawal after starting treatment can also be severe and requires urgent care.
Therapeutic indications
Naltrexone is used in two established treatment settings: alcohol use disorder and opioid dependence. The purpose is relapse prevention after the immediate risks of intoxication, withdrawal, and physical dependence have been assessed.
| Treatment setting | Clinical role | Main timing precaution |
|---|---|---|
| Alcohol use disorder | Reduces the rewarding effect of alcohol and may support reduced drinking or abstinence | It does not treat acute alcohol withdrawal |
| Opioid dependence | Blocks opioid effects and supports relapse prevention | Treatment must begin after an individually determined opioid-free period |
Alcohol use disorder relapse prevention
Naltrexone may reduce the reinforcing effect of alcohol, making drinking less rewarding for some patients. It is not a treatment for alcohol detox, seizures, delirium tremens, or other acute withdrawal complications. Detoxification and relapse-prevention treatment are separate stages.
A person with heavy alcohol use may require assessment of liver health, withdrawal risk, nutrition, sleep, and mental health before treatment begins. Naltrexone works alongside counselling, mutual-support planning, behavioural treatment, and strategies that reduce exposure to drinking triggers.
Opioid dependence relapse prevention
Naltrexone is used after opioid detoxification or another medically supervised transition. Starting too soon can trigger abrupt and severe withdrawal because the medicine displaces opioids from their receptors.
Treatment may help a person remain free from opioid effects, yet it does not eliminate cravings for every patient. The treatment plan should address housing, stress, pain, mental health, social support, and access to emergency overdose care. WHO guidance published in 2009 places medication within a wider programme for opioid dependence rather than treating it as a stand-alone solution [2].
LDN evidence and opioid compatibility
Research into LDN has explored pain, fatigue, inflammatory symptoms, and immune-related conditions, but results vary by condition and study quality. It should not be presented as an established cure for autoimmune disease, chronic pain, or healthy ageing.
Comparison
Naltrexone, methadone, and buprenorphine are distinct approaches to opioid dependence. An agonist activates opioid receptors; a partial agonist activates them less strongly; an antagonist blocks them.
| Treatment | Mechanism and initiation | Main clinical consideration |
|---|---|---|
| Naltrexone | Opioid antagonist; requires opioid-free preparation | Blocks opioid effects but can trigger withdrawal if started too soon |
| Methadone | Full opioid agonist; started within a supervised treatment plan | Reduces withdrawal and cravings but remains an opioid treatment |
| Buprenorphine | Partial opioid agonist; requires careful initiation | Reduces withdrawal and cravings with a ceiling effect on some opioid actions |
Methadone or buprenorphine may be considered when a person is still physically dependent on opioids and needs treatment that controls withdrawal and cravings. Naltrexone may suit someone who has completed opioid-free preparation and prefers an antagonist approach.
Suitability depends on current opioid use, treatment goals, pregnancy status, liver health, relapse risk, access to supervision, and the person’s ability to remain opioid-free before starting. Naloxone access and an emergency overdose plan remain relevant because tolerance can decline during treatment or after discontinuation.
The FDA label updated in 2023 also warns that attempts to overcome opioid blockade can produce fatal overdose when the medicine’s effect decreases [3].
Common mistakes
Several practical errors can reduce benefit or create avoidable danger:
- Starting after taking an opioid painkiller without telling the prescriber.
- Assuming a negative feeling of withdrawal means the body is opioid-free.
- Forgetting to mention naltrexone before surgery or dental treatment.
- Taking extra opioid medicine to overpower the blockade.
- Stopping treatment without a plan for cravings, relapse, and reduced tolerance.
- Treating naltrexone as a cure for acute alcohol withdrawal.
- Changing the dose because nausea or sleep changes are inconvenient.
- Assuming low-dose naltrexone will not affect opioid pain relief.
- Failing to update the medicine list after an emergency prescription.
One small detail matters during travel or a hospital visit: keep the medicine name and treatment information with your personal health records. Emergency teams may otherwise not realise why standard opioid pain treatment is failing.
If treatment stops, relapse planning becomes more important, not less. Reduced tolerance can make a previously familiar opioid amount dangerous.
What doctors say
In clinical practice, the first question is usually not simply whether naltrexone can block opioids. The key questions are whether the patient is genuinely opioid-free, whether withdrawal has been addressed, and whether the treatment plan covers relapse triggers and emergency risks.
A doctor will usually want a complete list of pain medicines, sleep medicines, cough products, alcohol use, and previous methadone or buprenorphine treatment. Hidden opioid exposure is one of the most important reasons initiation can go badly.
For alcohol use disorder, clinicians often frame naltrexone as one part of a longer plan. It may reduce reward from drinking, but it cannot manage withdrawal seizures, repair damaged relationships, or create recovery support by itself.
For opioid dependence, doctors also discuss the loss of tolerance. A person who stops naltrexone and returns to a former opioid dose can overdose more easily than before treatment. The 2021 SAMHSA treatment guidance describes medication choice as a shared clinical decision based on patient circumstances, treatment goals, and safety factors [4].
Common questions
Is Naltrexone suitable for older adults?
Older adults may use naltrexone when the prescriber considers liver function, kidney function, other medicines, fall risk, and the reason for treatment. The WHO guidance from 2009 supports individual assessment for medication treatment of opioid dependence rather than relying on age alone. Older patients may be more sensitive to dizziness, fatigue, dehydration, and medicine interactions. A complete medicine review is useful before treatment begins. Follow-up should reflect the person’s response.
What is the best time of day to take Naltrexone?
The best time depends on the prescribed schedule, sleep pattern, nausea, and other medicines. FDA prescribing information from 2023 allows the treating clinician to select a practical schedule that supports adherence and tolerability. Some people prefer morning dosing, while others take it later if tiredness occurs after the dose. Keep the time consistent unless the prescriber changes the plan.
What should happen after a missed dose?
Do not double the next dose after missing naltrexone. The FDA medication guidance from 2023 supports following the prescribed schedule and obtaining treatment-specific instructions when a dose is missed. Take the next dose only as directed by the clinician or treatment service. A missed dose is also a useful time to confirm that no opioid medicine was taken during the interruption.
Can Naltrexone be combined with other medicines or supplements?
Opioid medicines are the most important group to discuss because naltrexone blocks their effects. SAMHSA guidance from 2021 recommends medication reconciliation that includes methadone, buprenorphine, prescription pain medicines, cough products, and non-prescription products. Supplements and medicines that affect the liver also deserve review. Do not assume that a product is suitable merely because it is sold without a prescription.
Which diet, exercise, or habits help treatment work?
Regular meals, hydration, sleep routines, physical activity, and structured recovery support can make treatment easier to sustain. WHO resources from 2009 describe medication as part of wider psychosocial and behavioural care for dependence. Alcohol-related triggers, isolation, irregular sleep, and unmanaged pain can hinder progress. A written plan for cravings and high-risk situations is often more useful than relying on willpower alone.
What should be discussed with a doctor before starting Naltrexone?
Discuss every opioid exposure, including morphine, methadone, buprenorphine, tramadol, codeine, heroin, and opioid-containing cough or diarrhoea medicines. EMA safety information current in 2025 continues to support careful review of opioid-free status, liver health, and treatment history before initiation. Mention pregnancy, breastfeeding, liver disease, recent surgery, severe withdrawal, and previous reactions. The prescriber should determine the opioid-free preparation period and whether monitoring is needed.
What happens if Naltrexone is stopped?
Stopping naltrexone does not cause the same physical withdrawal pattern as stopping an opioid agonist, but relapse and overdose risks can increase. The FDA prescribing information from 2023 warns that opioid tolerance may fall during treatment, making a previous opioid amount dangerous after discontinuation. Do not restart opioids at a former dose to test whether the blockade has ended. Arrange a relapse-prevention and emergency-overdose plan before stopping treatment.
Do you offer anonymous delivery?
Your order will be securely packed and shipped within 24 hours. This is exactly what your package will look like (images of an actual item sent). It has the size and look of a regular private letter (24x11x0.7 cm) and its contents cannot be seen.
Sources
- U.S. Food and Drug Administration (2023). Naltrexone Hydrochloride Tablets, Prescribing Information.
- World Health Organization (2009). Guidelines for the Psychosocially Assisted Pharmacological Treatment of Opioid Dependence.
- U.S. Food and Drug Administration (2023). Medication Guide: Naltrexone Hydrochloride Tablets.
- Substance Abuse and Mental Health Services Administration (2021). Medications for Opioid Use Disorder.